Yaron Werber
Stock Analyst at TD Cowen
(4.95)
# 136
Out of 4,707 analysts
771
Total ratings
60%
Success rate
29.1%
Average return
Main Sectors:
Stocks Rated by Yaron Werber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMGN Amgen | Reiterated: Buy | $452 | $393.17 | +14.96% | 74 | Sep 8, 2026 | |
| IONS Ionis Pharmaceuticals | Maintained: Buy | $94 → $84 | $56.71 | +48.12% | 46 | Sep 8, 2026 | |
| ROIV Roivant Sciences | Maintained: Buy | $50 → $55 | $41.48 | +32.59% | 27 | Sep 8, 2026 | |
| RARE Ultragenyx Pharmaceutical | Rated: Buy | $49 → $18 | $14.88 | +20.97% | 46 | Sep 3, 2026 | |
| ARGX argenx SE | Reiterated: Buy | $1,146 → $1,353 | $1,007.07 | +34.35% | 56 | Aug 17, 2026 | |
| ASND Ascendis Pharma | Maintained: Buy | $325 → $341 | $270.09 | +26.25% | 28 | Aug 13, 2026 | |
| KLRA Kailera Therapeutics | Reiterated: Buy | $57 | $16.43 | +246.93% | 5 | Aug 13, 2026 | |
| LEGN Legend Biotech | Rated: Hold | $29 → $24 | $20.49 | +17.13% | 20 | Aug 12, 2026 | |
| SEPN Septerna | Maintained: Buy | n/a | $37.37 | - | 8 | Aug 11, 2026 | |
| GMAB Genmab | Rated: Buy | $43 | $33.53 | +28.24% | 26 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.47 | - | 25 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $19.11 | - | 19 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 | $57.67 | -4.63% | 35 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $424 → $454 | $351.48 | +29.17% | 45 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $150 | $109.13 | +37.45% | 12 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $30.06 | +99.60% | 21 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $6.61 | - | 19 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $227 | $269.12 | -15.76% | 1 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.7094 | - | 14 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $25.10 | - | 3 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $6.19 | - | 11 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.34 | - | 12 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $28.11 | - | 5 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $39.12 | - | 14 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.83 | - | 15 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $94 | $98.66 | -4.72% | 28 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.85 | - | 6 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | - | 12 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $3.23 | - | 11 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $230 | $336.98 | n/a | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €664.00 | €869.20 | n/a | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2,170.00 | n/a | 1 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.78 | n/a | 4 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $48.64 | n/a | 1 | Mar 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 → $3 | $8.22 | n/a | 6 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $7.82 | n/a | 2 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $684 → $565 | $810.31 | n/a | 30 | Feb 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $10.99 | n/a | 1 | Dec 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $3.71 | n/a | 10 | Aug 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.08 | n/a | 6 | Feb 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $4.91 | n/a | 6 | Dec 31, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $35.28 | n/a | 4 | Aug 12, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $497 → $345 | $212.50 | n/a | 16 | Feb 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $120 → $110 | $146.64 | n/a | 13 | Feb 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $266 → $94 | $9.39 | n/a | 5 | Sep 3, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $137 → $132 | $33.55 | n/a | 2 | Feb 18, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $37 | $10.23 | n/a | 1 | Nov 10, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $20.94 | n/a | 3 | Apr 22, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $5 | $47.37 | n/a | 5 | Jun 4, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $63 → $100 | $528.90 | n/a | 7 | Apr 19, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 | $0.0001 | n/a | 1 | Mar 12, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $48.54 | n/a | 1 | Nov 17, 2010 |
Amgen
Sep 8, 2026
Reiterated: Buy
Price Target: $452
Current: $393.17
Upside: +14.96%
Ionis Pharmaceuticals
Sep 8, 2026
Maintained: Buy
Price Target: $94 → $84
Current: $56.71
Upside: +48.12%
Roivant Sciences
Sep 8, 2026
Maintained: Buy
Price Target: $50 → $55
Current: $41.48
Upside: +32.59%
Ultragenyx Pharmaceutical
Sep 3, 2026
Rated: Buy
Price Target: $49 → $18
Current: $14.88
Upside: +20.97%
argenx SE
Aug 17, 2026
Reiterated: Buy
Price Target: $1,146 → $1,353
Current: $1,007.07
Upside: +34.35%
Ascendis Pharma
Aug 13, 2026
Maintained: Buy
Price Target: $325 → $341
Current: $270.09
Upside: +26.25%
Kailera Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: $57
Current: $16.43
Upside: +246.93%
Legend Biotech
Aug 12, 2026
Rated: Hold
Price Target: $29 → $24
Current: $20.49
Upside: +17.13%
Septerna
Aug 11, 2026
Maintained: Buy
Price Target: n/a
Current: $37.37
Upside: -
Genmab
Aug 7, 2026
Rated: Buy
Price Target: $43
Current: $33.53
Upside: +28.24%
Aug 6, 2026
Maintained: Hold
Price Target: n/a
Current: $2.47
Upside: -
Aug 6, 2026
Maintained: Buy
Price Target: n/a
Current: $19.11
Upside: -
Aug 5, 2026
Maintained: Buy
Price Target: $55
Current: $57.67
Upside: -4.63%
Aug 5, 2026
Maintained: Buy
Price Target: $424 → $454
Current: $351.48
Upside: +29.17%
Aug 5, 2026
Rated: Buy
Price Target: $150
Current: $109.13
Upside: +37.45%
Aug 4, 2026
Reiterated: Buy
Price Target: $60
Current: $30.06
Upside: +99.60%
Jun 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $6.61
Upside: -
May 18, 2026
Maintained: Buy
Price Target: $227
Current: $269.12
Upside: -15.76%
May 15, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.7094
Upside: -
May 13, 2026
Maintained: Buy
Price Target: n/a
Current: $25.10
Upside: -
May 13, 2026
Maintained: Buy
Price Target: n/a
Current: $6.19
Upside: -
May 12, 2026
Maintained: Buy
Price Target: n/a
Current: $1.34
Upside: -
May 8, 2026
Maintained: Buy
Price Target: n/a
Current: $28.11
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $39.12
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $4.83
Upside: -
May 5, 2026
Maintained: Hold
Price Target: $94
Current: $98.66
Upside: -4.72%
Apr 21, 2026
Downgraded: Hold
Price Target: n/a
Current: $4.85
Upside: -
Mar 31, 2026
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: -
Mar 26, 2026
Maintained: Buy
Price Target: n/a
Current: $3.23
Upside: -
May 21, 2025
Reiterated: Buy
Price Target: $230
Current: $336.98
Upside: n/a
Feb 21, 2025
Maintained: Buy
Price Target: €664.00
Current: €869.20
Upside: n/a
Apr 3, 2024
Maintained: Hold
Price Target: n/a
Current: $2,170.00
Upside: n/a
Mar 14, 2024
Downgraded: Hold
Price Target: n/a
Current: $4.78
Upside: n/a
Mar 11, 2024
Maintained: Buy
Price Target: n/a
Current: $48.64
Upside: n/a
Jun 26, 2023
Maintained: Hold
Price Target: $25 → $3
Current: $8.22
Upside: n/a
Nov 1, 2022
Downgraded: Hold
Price Target: n/a
Current: $7.82
Upside: n/a
Feb 8, 2021
Maintained: Hold
Price Target: $684 → $565
Current: $810.31
Upside: n/a
Dec 14, 2020
Initiated Coverage: Buy
Price Target: n/a
Current: $10.99
Upside: n/a
Aug 5, 2020
Maintained: Buy
Price Target: n/a
Current: $3.71
Upside: n/a
Feb 21, 2020
Rated: Hold
Price Target: n/a
Current: $4.08
Upside: n/a
Dec 31, 2019
Maintained: Hold
Price Target: n/a
Current: $4.91
Upside: n/a
Aug 12, 2019
Maintained: Hold
Price Target: n/a
Current: $35.28
Upside: n/a
Feb 25, 2016
Rated: Buy
Price Target: $497 → $345
Current: $212.50
Upside: n/a
Feb 25, 2016
Initiated Coverage: Buy
Price Target: $120 → $110
Current: $146.64
Upside: n/a
Sep 3, 2015
Initiated Coverage: Buy
Price Target: $266 → $94
Current: $9.39
Upside: n/a
Feb 18, 2015
Maintained: Hold
Price Target: $137 → $132
Current: $33.55
Upside: n/a
Nov 10, 2014
Initiated Coverage: Buy
Price Target: $37
Current: $10.23
Upside: n/a
Apr 22, 2014
Upgraded: Hold
Price Target: n/a
Current: $20.94
Upside: n/a
Jun 4, 2013
Maintained: Hold
Price Target: $7 → $5
Current: $47.37
Upside: n/a
Apr 19, 2013
Maintained: Buy
Price Target: $63 → $100
Current: $528.90
Upside: n/a
Mar 12, 2012
Downgraded: Hold
Price Target: $3
Current: $0.0001
Upside: n/a
Nov 17, 2010
Downgraded: Hold
Price Target: n/a
Current: $48.54
Upside: n/a